Bioxcel Therapeutics logo

Bioxcel Therapeutics Share Price Today

(NASDAQ: BTAI)

Bioxcel Therapeutics share price is $1.99 & ₹169.53 as on 30 Apr 2025, 2.30 'hrs' IST

$1.99

0.03

(1.53%)

Market is closed - opens 7 PM, 30 Apr 2025

View live Bioxcel Therapeutics share price in Dollar and Rupees. Guide to invest in Bioxcel Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bioxcel Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Bioxcel Therapeutics share price movements

  • Today's Low: $1.91
    Today's High: $2.09

    Day's Volatility :8.61%

  • 52 Weeks Low: $1.29
    52 Weeks High: $43.12

    52 Weeks Volatility :97.01%

Bioxcel Therapeutics (BTAI) Returns

PeriodBioxcel TherapeuticsSector (Health Care)Index (Russel 2000)
3 Months
-63.08%
-4.8%
0.0%
6 Months
-82.93%
-6.6%
0.0%
1 Year
-95.16%
-1.3%
0.0%
3 Years
-99.13%
6.4%
-5.1%

Bioxcel Therapeutics (BTAI) Key Statistics

in dollars & INR

Previous Close
$1.96
Open
$1.91
Today's High
$2.09
Today's Low
$1.91
Market Capitalization
$10.7M
Today's Volume
$58.0K
52 Week High
$43.12
52 Week Low
$1.29
Revenue TTM
$2.3M
EBITDA
$-64.5M
Earnings Per Share (EPS)
$-23.51
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1766.94%

How to invest in Bioxcel Therapeutics Stock (BTAI) from India?

It is very easy for Indian residents to invest directly in Bioxcel Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioxcel Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bioxcel Therapeutics or BTAI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioxcel Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioxcel Therapeutics shares which would translate to 0.428 fractional shares of Bioxcel Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bioxcel Therapeutics, in just a few clicks!

Returns in Bioxcel Therapeutics (BTAI) for Indian investors in Rupees

The Bioxcel Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bioxcel Therapeutics investment value today

Current value as on today

₹7,025

Returns

₹92,975

(-92.98%)

Returns from Bioxcel Therapeutics Stock

₹95,064 (-95.06%)

Dollar Returns

₹2,089 (+2.09%)

Indian investors sentiment towards Bioxcel Therapeutics (BTAI)

-82%

Period: Mar 30, 2025 to Apr 29, 2025. Change in 30 Days versus previous period

Search interest for Bioxcel Therapeutics Stock from India on INDmoney has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bioxcel Therapeutics

  • BlackRock Inc

    0.43%

  • Geode Capital Management, LLC

    0.34%

  • Wells Fargo & Co

    0.21%

  • Renaissance Technologies Corp

    0.15%

  • Millennium Management LLC

    0.15%

  • Bank of America Corp

    0.10%

Analyst Recommendation on Bioxcel Therapeutics

Rating
Trend

Buy

    69%Buy

    30%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Bioxcel Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Bioxcel Therapeutics Stock (BTAI)

What analysts predicted

Upside of 1721.61%

Target:

$36.25

Current:

$1.99

Insights on Bioxcel Therapeutics Stock (Ticker Symbol: BTAI)

  • Price Movement

    In the last 7 days, BTAI stock has moved up by 16.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 214.0K → 366.0K (in $), with an average increase of 41.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -13.65M → -10.85M (in $), with an average increase of 25.7% per quarter
  • BTAI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 73.0% return, outperforming this stock by 168.3%
  • BTAI vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 91.0% return, outperforming this stock by 190.1%
  • Price to Sales

    ForBTAI every $1 of sales, investors are willing to pay $2.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.

Bioxcel Therapeutics Technicals Summary

Sell

Neutral

Buy

Bioxcel Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Bioxcel Therapeutics (BTAI) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Bioxcel Therapeutics logo
-3.94%
-82.93%
-95.16%
-99.13%
-99.65%
Regeneron Pharmaceuticals, Inc. logo
-3.5%
-33.68%
-31.29%
-6.14%
16.46%
Beone Medicines Ltd logo
-8.24%
21.23%
62.23%
49.96%
78.11%
Vertex Pharmaceuticals Incorporated logo
2.53%
4.63%
26.54%
89.75%
95.01%
Alnylam Pharmaceuticals, Inc. logo
-5.61%
-9.46%
77.05%
83.29%
97.62%

About Bioxcel Therapeutics

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally dissolving film formulation of dexmedetomidine in development for the treatment of agitation associated with psychiatric and neurological disorders; and its immune-oncology candidate, BXCL 701, which is an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors. It also develops IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults; BXCL502 for the treatment of stress-related neuropsychiatric symptoms in dementia and other stress-related disorders; BXCL503, a drug candidate to target apathy in dementia; and BXCL504, which has the potential to address apathy and aggression in dementia. BioXcel Therapeutics, Inc. was incorporated in 2017 and is headquartered in New Haven, Connecticut.
Organization
Bioxcel Therapeutics
Employees
37
CEO
Dr. Vimal D. Mehta Ph.D.
Industry
Health Technology

Management People of Bioxcel Therapeutics

NameTitle
Dr. Vimal D. Mehta Ph.D.
Founder, CEO, President, & Director
Mr. Richard I. Steinhart MBA
Senior VP & CFO
Mr. Javier Rodriguez J.D.
Senior VP, Chief Legal Officer & Corporate Secretary
Dr. Frank D. Yocca Ph.D.
Executive VP & Chief Scientific Officer

Important FAQs about investing in BTAI Stock from India :

What is Bioxcel Therapeutics share price today?

Bioxcel Therapeutics share price today stands at $1.99, Open: $1.91 ; Previous Close: $1.96 ; High: $2.09 ; Low: $1.91 ; 52 Week High: $43.12 ; 52 Week Low: $1.29.

The stock opens at $1.91, after a previous close of $1.96. The stock reached a daily high of $2.09 and a low of $1.91, with a 52-week high of $43.12 and a 52-week low of $1.29.

Can Indians buy Bioxcel Therapeutics shares?

Yes, Indians can invest in the Bioxcel Therapeutics (BTAI) from India.

With INDmoney, you can buy Bioxcel Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bioxcel Therapeutics at zero transaction cost.

How can I buy Bioxcel Therapeutics shares from India?

It is very easy to buy Bioxcel Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioxcel Therapeutics (BTAI) be purchased?

Yes, you can buy fractional shares of Bioxcel Therapeutics with INDmoney app.

What are the documents required to start investing in Bioxcel Therapeutics stocks?

To start investing in Bioxcel Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bioxcel Therapeutics Stock (BTAI)?

Today’s highest price of Bioxcel Therapeutics (BTAI) is $2.09.

Today’s lowest price of Bioxcel Therapeutics (BTAI) is $1.91.

What is today's market capitalisation of Bioxcel Therapeutics?

Today's market capitalisation of Bioxcel Therapeutics BTAI is 10.7M

What is the 52 Week High and Low Range of Bioxcel Therapeutics Stock (BTAI)?

  • 52 Week High

    $43.12

  • 52 Week Low

    $1.29

What are the historical returns of Bioxcel Therapeutics (BTAI)?

  • 1 Month Returns

    -3.94%

  • 3 Months Returns

    -82.93%

  • 1 Year Returns

    -95.16%

  • 5 Years Returns

    -99.65%

Who is the Chief Executive Officer (CEO) of Bioxcel Therapeutics ?

Dr. Vimal D. Mehta Ph.D. is the current Chief Executive Officer (CEO) of Bioxcel Therapeutics.